Source: ALL
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
group | 0.400 | None | 1.000 | 43 | 0 | 1990 | 2020 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
group | 0.070 | None | 0.714 | 7 | 0 | 2002 | 2020 | ||||||||
|
caspase 1 | 0.413 | 0.885 | 3.5E-05 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2020 | ||||||||
|
transmembrane protein 132A | 0.792 | 0.308 | 2.0E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha | 0.569 | 0.769 | 4.4E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
galectin 1 | 0.435 | 0.846 | 4.5E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
protein inhibitor of activated STAT 1 | 0.633 | 0.731 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
insulin receptor | 0.432 | 0.846 | 3.6E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
sarcoglycan alpha | 0.592 | 0.654 | 2.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
KCNQ1 opposite strand/antisense transcript 1 | 0.534 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
renin binding protein | 0.528 | 0.769 | 0.45 |
|
group | 0.100 | None | 0.909 | 11 | 0 | 2001 | 2019 | ||||||||
|
haptoglobin | 0.412 | 0.885 | 1.7E-05 |
|
group | 0.370 | None | 1.000 | 8 | 0 | 2010 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.370 | None | 0.875 | 8 | 0 | 2003 | 2019 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2019 | ||||||||
|
glyoxalase I | 0.537 | 0.769 | 9.7E-07 |
|
group | 0.040 | None | 1.000 | 4 | 2 | 2011 | 2019 | ||||||||
|
diabetic nephropathy | 0.678 | 0.500 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2011 | 2019 | |||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2019 | ||||||||
|
solute carrier family 5 member 2 | 0.499 | 0.769 | 4.9E-14 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
sucrase-isomaltase | 0.569 | 0.692 | 3.9E-60 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
glucagon | 0.431 | 0.885 | 3.5E-02 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 |